AbbVie (ABBV) Insider Trading & Ownership $195.17 +6.15 (+3.25%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$195.10 -0.07 (-0.04%) As of 08/1/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AbbVie (NYSE:ABBV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.25%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$36.14M Get ABBV Insider Trade Alerts Want to know when executives and insiders are buying or selling AbbVie stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ABBV Insider Buying and Selling by Quarter AbbVie Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/28/2025Ro KhannaU.S. Congress Member (D-CA)Buy$182.98$15,001 - $50,0005/22/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$182.32$1,001 - $15,0005/15/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Buy$181.52$1,001 - $15,0005/5/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$196.04$1,001 - $15,0004/17/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$172.78$1,001 - $15,0004/17/2025Jefferson ShreveU.S. Congress Member (R-IN)Sell$172.78$50,001 - $100,0004/8/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Sell$175.03$1,001 - $15,0004/7/2025Jared MoskowitzU.S. Congress Member (D-FL)Buy$186.11$1,001 - $15,0004/3/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$201.31$1,001 - $15,0004/3/2025Dwight EvansU.S. Congress Member (D-PA)Sell$201.31$1,001 - $15,0004/1/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$206.08$1,001 - $15,0003/31/2025Jeffrey Ryan StewartEVPSell58,832$210.08$12,359,426.56 3/17/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$214.45$1,001 - $15,0002/26/2025Kevin K BuckbeeSVPSell18,944$203.41$3,853,399.04 2/26/2025Timothy J RichmondEVPSell29,917$202.90$6,070,159.30 2/25/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Buy$204.19$1,001 - $15,0002/24/2025Jefferson ShreveU.S. Congress Member (R-IN)Buy$204.02$50,001 - $100,0002/20/2025Perry C SiatisEVPSell5,778$197.90$1,143,466.20 1/15/2025Jared MoskowitzU.S. Congress Member (D-FL)Buy$171.32$1,001 - $15,00012/16/2024Kevin K BuckbeeSVPSell1,800$172.24$310,032.00 12/6/2024Virginia FoxxU.S. Congress Member (R-NC)Buy$176.18$1,001 - $15,00011/20/2024Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$167.74$1,001 - $15,0009/4/2024John JamesU.S. Congress Member (R-MI)Sell$197.00$1,001 - $15,0008/5/2024Richard A GonzalezChairmanSell66,500$186.52$12,403,580.00 (Data available from 1/1/2013 forward) ABBV Insider Trading Activity - Frequently Asked Questions Who is on AbbVie's Insider Roster? The list of insiders at AbbVie includes Azita Saleki-Gerhardt, Carrie C Strom, Elaine K Sorg, Jeffrey Ryan Stewart, Kevin K Buckbee, Nicholas Donoghoe, Perry C Siatis, Richard A Gonzalez, Robert A Michael, Roxanne S Austin, Scott T Reents, and Timothy J Richmond. Learn more on insiders at ABBV. What percentage of AbbVie stock is owned by insiders? 0.25% of AbbVie stock is owned by insiders. Learn more on ABBV's insider holdings. Which AbbVie insiders have been selling company stock? The following insiders have sold ABBV shares in the last 24 months: Azita Saleki-Gerhardt ($9,184,047.70), Jeffrey Ryan Stewart ($22,898,918.27), Kevin K Buckbee ($5,072,118.64), Nicholas Donoghoe ($4,167,301.24), Perry C Siatis ($5,339,325.72), Richard A Gonzalez ($86,473,913.32), Robert A Michael ($12,153,699.55), Scott T Reents ($2,509,001.60), and Timothy J Richmond ($6,070,159.30). How much insider selling is happening at AbbVie? Insiders have sold a total of 850,852 AbbVie shares in the last 24 months for a total of $153,868,485.34 sold. Which members of congress are trading AbbVie? Ro Khanna (D-CA), Josh Gottheimer (D-NJ), Robert Bresnahan, Jr. (R-PA), Marjorie Taylor Greene (R-GA), Jared Moskowitz (D-FL), Jefferson Shreve (R-IN), and Virginia Foxx (R-NC) have bought shares of AbbVie in the last year totaling $195,500. Josh Gottheimer (D-NJ), Jefferson Shreve (R-IN), Robert Bresnahan, Jr. (R-PA), Dwight Evans (D-PA), and John James (R-MI) have sold shares totaling $107,000. AbbVie Key ExecutivesMr. Richard A. Gonzalez (Age 70)Chairman & CEO Compensation: $7.19MMr. Robert A. Michael (Age 54)President & COO Compensation: $4.62MMr. Scott T. Reents (Age 56)Executive VP & CFO Compensation: $3.13MDr. Azita Saleki-Gerhardt Ph.D. (Age 61)Executive VP & COO Compensation: $3.51MMr. Jeffrey Ryan Stewart (Age 55)Executive VP & Chief Commercial Officer Compensation: $4.32M1 recent tradesDr. Thomas J. Hudson M.D. (Age 62)Senior VP & Chief Scientific Officer of Global Research Ms. Elizabeth SheaSenior Vice President of Investor RelationsMr. Perry C. Siatis (Age 49)Executive VP, General Counsel & Secretary 1 recent tradesMr. Sanjay NarayanSenior VP, Chief Ethics, Compliance Officer & Allergan Aesthetic LegalMr. Timothy J. Richmond (Age 58)Executive VP & Chief Human Resources Officer Compensation: $1.12M1 recent trades More Insider Trading Tools from MarketBeat Related Companies Amgen Insider Ownership Gilead Sciences Insider Ownership Moderna Insider Ownership Abbott Laboratories Insider Ownership Bristol Myers Squibb Insider Ownership Johnson & Johnson Insider Ownership Eli Lilly and Company Insider Ownership Merck & Co., Inc. Insider Ownership Pfizer Insider Ownership Zoetis Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NYSE:ABBV) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
